Europe's pharmaceutical industry presents a nuanced landscape rife with both challenges. Governments across the continent are increasingly demanding stringent guidelines while patients seek affordable treatments. This transformative environment necessitates a proactive approach for pharmaceutical companies looking to succeed. Professionals must met